BioSpace News Archive

Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced the closing of its previously announced registered direct offering of 3,650,840 shares of its common stock, at a purchase price of $0.842 per share, which was priced at-the-market under Nasdaq rules.

Rejuveron Life Sciences AG, a Zürich-based biotechnology company developing technologies for healthy aging, today announced the appointment of biomedical gerontologist, Dr. Aubrey de Grey, to its Scientific Advisory Board (SAB).

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announced that the National Medical Products Administration (

Aspen Technology, Inc., a global leader in asset optimization software, has appointed David Leitham as Senior Vice President and General Manager to lead the company’s pharmaceutical industry growth strategy.

Platform Designed to Exactly Locate Early Cancer and Thereby Make It Actionable, Based on Novel “Synthetic Biopsy” Technology Licensed from Stanford University

Rapid Micro Biosystems, the leading provider of automated, non-destructive, rapid microbial detection, is pleased to announce the appointment of John Wilson as Chief Operating Officer reporting directly to the company’s CEO, Robert Spignesi.

BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that the Company installed its PURE EP(tm) System and conducted first patient cases at Memorial Hospital of South Bend, part of Beacon Health System, in South Bend, India

Today, the U.S. Food and Drug Administration released the agency’s first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan . This action plan describes a multi-pronged approach to advance the Agency’s oversight of AI/ML-based medical software.

Toland joins Andrew Cleeland (Chairman of the Board, MMI) in developing the field of robotic-assisted microsurgery

Indonesian paint manufacturer PT Mowilex is safeguarding workers’ health by purchasing COVID-19 diagnostic tests from U.S. health care company Abbott.